论文部分内容阅读
卡铂是近年来临床上较引人注目的药物之一。我们用卡铂联合５氟脲嘧啶治疗７例晚期恶性肿瘤合并腹水病人，总缓解率８５．７％。本方案中最常见的副反应为血象改变及消化系统反应，对肝、肾功无影响。无腹膜刺激症状发生。
Carboplatin is one of the more clinically attractive drugs in recent years. We treated with carboplatin combined with 5-fluorouracil in 7 patients with advanced malignancy ascites, the overall response rate was 85.7%. The most common side effects of this program for blood changes and digestive system reactions, no effect on the liver and kidney function. No peritoneal irritation occurs.